• gb_flag germany_flag japan_flag korea_flag china_flag
  • Home
  • About
    • Diversity & Inclusion
      • Initiatives & Events
      • Inspirational Innovators
    • Awards
    • History
  • Team
  • Services
    • Create & Protect
    • Patents
    • Trade Marks & Brands
    • Designs
    • Copyright
    • Domain Names
    • IP Strategy
    • IP Due Diligence
    • IP Audits & Health Checks
    • Brand Strategy
    • IP Exploitation & Commercial Issues
    • IP Searching & Clearance
    • Disputes & Litigation
    • Litigation
    • Oppositions & Cancellation Actions
    • Arbitration & Mediation
    • Online Enforcement & Anti-counterfeiting
    • Domain Name Disputes
    • UP & UPC
    • Unitary patents
    • Unified Patent Court
    • Representation
    • Revocation
    • Infringement
  • Sectors
    • Artificial Intelligence
    • Biotechnology, Chemistry & Pharmaceuticals
    • Business & Finance
    • Creative, Entertainment, Hospitality & Media
    • Consumer, Luxury & Fashion Goods
    • Electronics, Engineering & IT
    • Energy
    • Medical Technologies
  • Clients
    • Spin-outs, Start-Ups & SMEs
    • Academics & Tech Transfer
    • Inventors
    • Overseas Law Agencies
    • In-house Counsel & Corporates
    • Venture Capitalists & Investors
  • News & Events
  • Knowledge Bank
    • IP Cases & Articles
    • Webinars & Videos
    • FAQs and Guides
    • Newsletters
    • UP & UPC
  • Careers
    • Current Vacancies
    • Diversity & Inclusion
    • Open days
    • Knowledge & Learning
    • What Our Team Says
  • Contact Us
gb_flag germany_flag japan_flag korea_flag china_flag

Search results for "" 2292 results found

Sort By By Date By Relevance
  • IP Cases & Articles

    T 1123/16 & T 2963/19: clinical trial protocols as closest prior art

    Posted on 16 August 2022
    Two recent decisions from the EPO Board of Appeal considered whether clinical trial protocols provide the skilled person with a reasonable expectation of success. The decisions add to the growing body of case law in this area.
    Gemma Seabright
    Gemma Seabright
    Associate, Patent Attorney
  • IP Cases & Articles

    Issues concerning the grant of machine learning patents at the EPO

    Posted on 16 August 2022
    How much information should you include in your machine learning (ML) patent application to give it the best chance of being granted by the European Patent Office (EPO)?
  • IP Cases & Articles

    UK R&D tax credit landscape - upcoming proposed changes

    Posted on 16 August 2022
    In what is clearly good news for many, the UK Government has drafted a number of pleasing changes to the UK research and development tax credit landscape. These changes follow from the recent consultation which the UK Government held on this point, which we previously reported on.
    William Burrell
    William Burrell
    Partner, Patent Attorney
  • IP Cases & Articles

    Sandoz v Teva UK: revocation of UK formulation patents for blockbuster drug, Apixaban

    Posted on 16 August 2022
    Eliquis®, the Bristol Myers Squibb (BMS) and Pfizer apixaban product, was recently ranked in the top five pharmaceutical products sold worldwide, with a significant increase in demand resulting from the Covid-19 pandemic. Enforceability of BMS and Pfizer’s patent portfolio will clearly be critical to the ongoing success of this blockbuster…
    Laura Jennings
    Laura Jennings
    Senior Associate, Patent Attorney
  • IP Cases & Articles

    T 3000/19: how do you solve a problem like video evidence?

    Posted on 16 August 2022
    A European Patent Office (EPO) Board of Appeal was recently asked to consider a case where an online video was cited against a patent application, with just one problem: the video was no longer available. In T 3000/19, the Board of Appeal addressed what should be done when electronic evidence…
    Ben Hunter
    Ben Hunter
    Senior Associate, Patent Attorney
  • IP Cases & Articles

    Artificial intelligence originating inventions: can an AI system be designated as inventor?

    Posted on 16 August 2022
    Artificial Intelligence (AI) is a rapidly developing area of technology. AI systems are now capable of driving autonomous cars, performing translation of text, and assisting in healthcare and construction. AI systems are even capable of beating humans in games such as chess – an achievement which was originally considered out…
    Simon Schofield
    Simon Schofield
    Senior Associate, Patent Attorney
  • IP Cases & Articles

    CNIPA and EPO: Examination trends for business method related inventions

    Posted on 16 August 2022
    In our previous article “Computer implemented inventions (CII) in CNIPA and the EPO - recent developments of examination practice”, we briefly discussed the China National Intellectual Property Administration’s (CNIPA’s) approaches of examining CII patent applications under the proposed amendments to the China Patent Examination Guidelines and compared them to the…
    Nigel Lee
    Nigel Lee
    Associate, Patent Attorney
  • Team

    Chris Weekes

    I joined the biotechnology, chemistry and pharmaceutical team at D Young & Co in 2022. My background is primarily in molecular biology and biochemistry, with experience in immunology and immunotherapy. Since joining the firm, I have been introduced to a range of areas of patent law, including drafting, prosecution and…
  • IP Cases & Articles

    Next level registered IP protection for visual characteristics of products - trade marks

    Posted on 01 August 2022
    When it comes to protecting the appearance of products with registered intellectual property rights in the UK and other parts of Europe at least, quite rightly one of the best ways to obtain this protection is through the usage of registered designs, which provide for a period of protection lasting…
    Richard Burton
    Richard Burton
    Partner, Trade Mark Attorney
    William Burrell
    William Burrell
    Partner, Patent Attorney
  • IP Cases & Articles

    Montenegro to become 39th EPC contracting state on 01 October 2022

    Posted on 28 July 2022
    Since Albania (AL) became an EPC contracting state on 01 May 2010, the European Patent Organisation had unchanged 38 contracting states for over 12 years. However, on 01 October 2022, Montenegro (ME) will become the 39th EPC contracting state, after initially being an extension state from 01 March 2010 onwards.
    Hanns-Juergen Grosse
    Hanns-Juergen Grosse
    Partner, Patent Attorney

Page 75 of 230

Previous Next
  • Show all
  • Cases & Articles (1582)
  • Webinars & Videos (55)
  • News (183)
  • Events (10)
  • FAQs & Guides (16)
  • Newsletters (263)
  • About (5)
  • Sectors (8)
  • Services (20)
  • Clients (6)
  • Offices (3)
  • Team (136)
  • Vacancy (5)
  • General
About Team Services Sectors Clients Knowledge Bank
Careers Privacy Policy Cookies Policy Modern Slavery Statement Urgent Instructions LLP List of Members
Contact us mail@dyoung.com +44 (0)20 7269 8550
London Munich Southampton
© Copyright 2010-2026 D Young & Co. All rights reserved.

Sharing IP information such as new legislation, relevant case law, market trends and other topical issues is important to us. We send out our IP newsletters by email about once a month, publish IP books annually, share occasional IP news alerts and also invitations to our IP events such as webinars and seminars. We take your privacy seriously and you can change your mailing preferences or unsubscribe at any time.

To sign up to our marketing communications, please fill out this form.

Your contact details

Name

What would you like to hear from us about?

Patent news
Patent webinars
Biotech patent webinars
UP & UPC News
UP & UPC Webinars
SPC webinars
Trade mark news
Trade mark webinars
IPEC news & webinars
Design news
Design webinars

You can contact us at subscriptions@dyoung.com, telephone +44 (0) 20 7269 8850 or write to us at D Young & Co LLP, 3 Noble Street, London, EC2V 7BQ to update your preferences at any time.

We use cookies in our email marketing communications. You can view our privacy policy here and cookie policy here.

Almost finished! Submit this form and we will send you an email for you to confirm your preferences.

We use cookies in our email marketing communications. You can view our privacy policy here and cookie policy here.